files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 18, Issue 10 (2024)

References

  1. Kanda N., 2021. Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Mol. Sci., 22: 1-10.
  2. Greb J.E., A.M. Goldminz, J.T. Elder, M.G. Lebwohl, D.D. Gladman and J.J. Wu, et al., 2016.  Psoriasis.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Nat Rev Dis Primers., 2: 1-10.
  3. Campanati, A., A. Marani, E. Martina, F. Diotallevi, G. Radi and A. Offidani, 2021. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, Vol. 9, 11. 10.3390/biomedicines9111511.
  4. Singh, S., P. Young and A.W. Armstrong, 2017. An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies. PLOS ONE, Vol. 12. 10.1371/journal.pone.0181039.
  5. Langan, S.M., N.M. Seminara, D.B. Shin, A.B. Troxel and S.E. Kimmel et al., 2012. Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom. J. Invest. Dermatol., 132: 556-562.
  6. Praveenkumar U., et al., 2016. Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 10: 1-10.
  7. Zindancı, I., O. Albayrak, M. Kavala, E. Kocaturk, B. Can, S. Sudogan and M. Koç, 2012. Prevalence of Metabolic Syndrome in Patients with Psoriasis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Sci. World J., Vol. 2012. 10.1100/2012/312463 1-10.
  8. Barros, G., P. Duran, I. Vera and V. Bermúdez, 2022. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Mol. Sci., Vol. 23. 10.3390/ijms23147499 1-10.
  9. Schmitt, J. and G. Wozel, 2005. The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Dermatology, 210: 1-10.
  10. Etgü, F. and E. Dervis, 2024. Prevalence of Metabolic Syndrome in Patients With Psoriasis Vulgaris: A Hospital-Based Cross-Sectional Study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Cureus, Vol. 0. 10.7759/cureus.68037 1-10.
  11. Morgaonkar, M., R. Kushwaha, S. Gupta, S.K. Jain, D.V. Kulkarni and C.P. Sharma, 2016. Prevalence of metabolic syndrome in psoriasis vulgaris: A cross sectional study from a tertiary care hospital of South-East Rajasthan. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Res. Dermatol., Vol. 2. 10.18203/issn.2455-4529.intjresdermatol20162832 1-10.
  12. Parodi, A., N. Aste, C. Calvieri, F. Cantoresi and M. Carlesimo et al., 2014. Metabolic Syndrome Prevalence in Psoriasis: a cross-sectional study in the Italian population.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Am. J. Clin. Dermatol., 15: 1-10.
  13. Liu, L., X. ‐c Cai, X. ‐y Sun, Y. ‐q Zhou and M. ‐z Jin et al., 2022. Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: Current evidence. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Eur. Acad. Dermatol. Venereology, 36: 1-10.
  14. Kim, H.N., K. Han, S.W. Song and J.H. Lee, 2018. Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, PLOS ONE, Vol. 13. 10.1371/journal.pone.0202854 1-10.
  15. Parraga, S.P. and S.R. Feldman, 2024. Insulin resistance and psoriasis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Br. J. Dermatol., 191: 1-10.
  16. Asha, K., A. Singal, S.B. Sharma, V.K. Arora and A. Aggarwal, 2017. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Indian J. Med. Res., 146: 1-10.
  17. Pietrzak, A., A. Michalak-Stoma, G. Chodorowska and J.C. Szepietowski, 2010. Lipid Disturbances in Psoriasis: An Update. Mediators Inflammation, Vol. 2010. 10.1155/2010/535612.
  18. Armstrong, A.W., C.T. Harskamp and E.J. Armstrong, 2013. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Am. Acad. Dermatol., 68: 1-10.
  19. Qiao, J., Q.N. Jia and H.Z. Jin, 2020. Association between metabolic syndrome and psoriasis: A meta-analysis of observational studies with non-psoriasis control groups. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Arch. Med. Sci., 17: 1-10.